Characterization of an artificial antigen-presenting cell to propagate CD19-specific cytolytic T cells

被引：25

作者：

Numbenjapon, T. ^{[1
]}

Serrano, L. M.

Singh, H.

Kowolik, C. M.

Olivares, S.

Gonzalez, N.

Chang, W. C.

Forman, S. J.

Jensen, M. C.

Cooper, L. J. N.

机构：

[1] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA

[3] Beckman Res Inst, Div Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA

[4] Beckman Res Inst, Div Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

[5] Beckman Res Inst, Div Pediat Hematol Oncol, Duarte, CA USA

[6] Phramongkutklao Royal Thai Army Hosp & Coll Med, Dept Med, Div Hematol, Bangkok, Thailand

[7] Univ Texas, MD Anderson Canc Ctr, Childrens Canc Hosp, Div Pediat, Houston, TX 77030 USA

来源：

LEUKEMIA | 2006年 / 20卷 / 10期

关键词：

D O I：

10.1038/sj.leu.2404329

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1889 / 1892

页数：4

共 8 条

[1] Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 [J].

Brentjens, RJ ;

Latouche, JB ;

Santos, E ;

Marti, F ;

Gong, MC ;

Lyddane, C ;

King, PD ;

Larson, S ;

Weiss, M ;

Rivière, I ;

Sadelain, M .

NATURE MEDICINE, 2003, 9 (03) :279-286

[2] Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1 [J].

Cooper, LJN ;

Al-Kadhimi, Z ;

Serrano, LM ;

Pfeiffer, T ;

Olivares, S ;

Castro, A ;

Chang, WC ;

Gonzalez, S ;

Smith, D ;

Forman, SJ ;

Jensen, MC .

BLOOD, 2005, 105 (04) :1622-1631

[3] T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect [J].

Cooper, LJN ;

Topp, MS ;

Serrano, LM ;

Gonzalez, S ;

Chang, WC ;

Naranjo, A ;

Wright, C ;

Popplewell, L ;

Raubitschek, A ;

Forman, SJ ;

Jensen, MC .

BLOOD, 2003, 101 (04) :1637-1644

[4] Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia [J].

Imai, C ;

Mihara, K ;

Andreansky, M ;

Nicholson, IC ;

Pui, CH ;

Geiger, TL ;

Campana, D .

LEUKEMIA, 2004, 18 (04) :676-684

[5] Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB [J].

Maus, MV ;

Thomas, AK ;

Leonard, DGB ;

Allman, D ;

Addya, K ;

Schlienger, K ;

Riley, JL ;

June, CH .

NATURE BIOTECHNOLOGY, 2002, 20 (02) :143-148

[6] THE USE OF ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES TO CLONE AND EXPAND HUMAN ANTIGEN-SPECIFIC T-CELLS [J].

RIDDELL, SR ;

GREENBERG, PD .

JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 128 (02) :189-201

[7] Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors [J].

Rossig, C ;

Bär, A ;

Pscherer, S ;

Altvater, B ;

Pule, M ;

Rooney, CM ;

Brenner, MK ;

Jürgens, H ;

Vormoor, J .

JOURNAL OF IMMUNOTHERAPY, 2006, 29 (01) :21-31

[8] Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posarcansplantation adoptive immunotherapy [J].

Serrano, LM ;

Pfeiffer, T ;

Olivares, S ;

Numbenjapon, T ;

Bennitt, J ;

Kim, D ;

Smith, D ;

McNamara, G ;

Al-Kadhimi, Z ;

Rosenthal, J ;

Forman, SJ ;

Jensen, MC ;

Cooper, LJN .

BLOOD, 2006, 107 (07) :2643-2652

← 1 →